| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | HSP90B1 MCM8 CENPE ATP13A1 MYO9B DDX52 CCT7 MORC2 DNAH7 DNAH1 BLM BPTF SLFN13 ABCB11 MACF1 SLFN11 ACSM2A ACSM2B | 2.43e-06 | 614 | 161 | 18 | GO:0140657 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | HSP90B1 MCM8 ATP13A1 MYO9B DDX52 CCT7 MORC2 DNAH7 BLM SLFN13 ABCB11 MACF1 SLFN11 | 6.16e-05 | 441 | 161 | 13 | GO:0016887 |
| GeneOntologyMolecularFunction | benzoate-CoA ligase activity | 1.93e-04 | 3 | 161 | 2 | GO:0018858 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | PUS3 CMTR1 MCM8 DDX52 REV3L TRMT2B POLR3A FAN1 BLM DUS2 BPTF DCLRE1C SLFN13 SLFN11 EXOSC7 | 2.35e-04 | 645 | 161 | 15 | GO:0140640 |
| GeneOntologyMolecularFunction | decanoate-CoA ligase activity | 3.84e-04 | 4 | 161 | 2 | GO:0102391 | |
| Pubmed | DOCK3 HSP90B1 ATP13A1 USP11 LONRF1 UBR4 MRPS35 CCT7 HUWE1 ACTR3B REV3L UBASH3A CPNE5 INTS8 FAN1 RCBTB1 PRKAR1A MACF1 ASTN2 TLN2 ATIC ATM GFPT2 ARHGAP21 AGTPBP1 | 4.24e-09 | 1285 | 170 | 25 | 35914814 | |
| Pubmed | DOCK3 KCTD12 KNTC1 GBF1 CMTR1 ATP13A1 RC3H1 MORC2 FAN1 PARP4 SETD2 MACF1 ASTN2 SSH2 MGA | 2.36e-08 | 493 | 170 | 15 | 15368895 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | BDP1 KNTC1 CENPE MYO9B USP11 HUWE1 NCKAP5L RUFY1 BLM SETD2 NFATC3 BANP MACF1 SLFN11 ZMYM6 | 2.31e-07 | 588 | 170 | 15 | 38580884 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | ASXL1 GBF1 HK3 CMTR1 MYO9B USP11 DDX52 UBR4 APOA2 HUWE1 REV3L MORC2 BLM BPTF RCBTB1 BANP MGA AGTPBP1 | 2.45e-07 | 857 | 170 | 18 | 25609649 |
| Pubmed | HSP90B1 GBF1 CHERP DRG2 CENPE MED16 ATP13A1 MYO9B DDX52 UBR4 LPCAT4 DGKA RHOT2 HUWE1 POLR3A PARP4 PRKAR1A ATIC LAS1L KDSR | 1.26e-06 | 1168 | 170 | 20 | 19946888 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | KCTD12 KNTC1 HSP90B1 GBF1 CHERP ATP13A1 DDX52 UBR4 MRPS35 DUOX2 CCT7 APOB HUWE1 F2 POLR3A DFFA TGM3 PRKAR1A CSTF3 TLN2 ATIC ATM | 1.95e-06 | 1425 | 170 | 22 | 30948266 |
| Pubmed | Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes? | 2.07e-06 | 170 | 170 | 8 | 23314748 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | DOCK3 KCTD12 GBF1 ATP13A1 MYO9B LONRF1 SPEG MAEA UBR4 SLC10A3 ICE1 RHOT2 HUWE1 REV3L TLNRD1 BANP NPRL3 TLN2 ARHGAP21 | 2.22e-06 | 1105 | 170 | 19 | 35748872 |
| Pubmed | MCM8 ARRDC4 USP11 DDX52 LPCAT4 L1TD1 RHOT2 REV3L NCKAP5L BPTF SETD2 ACTL8 PCDH19 ASS1 MACF1 SLFN11 TRAF3IP3 MGA AGTPBP1 | 2.56e-06 | 1116 | 170 | 19 | 31753913 | |
| Pubmed | 2.79e-06 | 177 | 170 | 8 | 26206133 | ||
| Pubmed | MED16 USP11 UBR4 CCT7 MORC2 POLR3A BLM BPTF S100A11 DFFA SETD2 PAPOLA PHF3 ASS1 CSTF3 ATIC ATM | 1.09e-05 | 1014 | 170 | 17 | 32416067 | |
| Pubmed | 1.13e-05 | 282 | 170 | 9 | 23667531 | ||
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 1.25e-05 | 361 | 170 | 10 | 26167880 | |
| Pubmed | KNTC1 CHERP DRG2 CENPE ATP13A1 ICE1 HUWE1 NCKAP5L SETD2 PHF3 BANP ATIC MGA AGTPBP1 | 1.64e-05 | 733 | 170 | 14 | 34672954 | |
| Pubmed | CHERP USP11 DDX52 UBR4 HUWE1 BLM BPTF TGM3 PHF3 MACF1 ATIC ATM LAS1L | 2.16e-05 | 653 | 170 | 13 | 22586326 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 27419389 | ||
| Pubmed | Thrombogenic potential of picomolar coagulation factor XIa is mediated by thrombin wave propagation. | 2.38e-05 | 2 | 170 | 2 | 36724509 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 25953375 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 15072993 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 19634011 | ||
| Pubmed | Activation of factor XI by products of prothrombin activation. | 2.38e-05 | 2 | 170 | 2 | 21527525 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 10823824 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 19779458 | ||
| Pubmed | High expression of CPNE5 and CPNE9 predicts positive prognosis in multiple myeloma. | 2.38e-05 | 2 | 170 | 2 | 33780365 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 16521160 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 12034743 | ||
| Pubmed | Artemis-dependent DNA double-strand break formation at stalled replication forks. | 2.38e-05 | 2 | 170 | 2 | 23465063 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 29948332 | ||
| Pubmed | Metabolism of apolipoprotein A-II containing triglyceride rich ApoB lipoproteins in humans. | 2.38e-05 | 2 | 170 | 2 | 26071654 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 37833372 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 18401830 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 22730303 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 21596788 | ||
| Pubmed | CKIP-1 recruits nuclear ATM partially to the plasma membrane through interaction with ATM. | 2.38e-05 | 2 | 170 | 2 | 16325375 | |
| Pubmed | Mitosis. Microtubule detyrosination guides chromosomes during mitosis. | 2.38e-05 | 2 | 170 | 2 | 25908662 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 29563550 | ||
| Pubmed | KNTC1 HSP90B1 MYLK PDGFA PCDHGA4 DDX52 UBR4 LPCAT4 DGKA MRPS35 DUOX2 MSL1 APOB SFMBT2 BPTF PKHD1 ANKRD30A MACF1 ATM ARHGAP21 | 2.77e-05 | 1442 | 170 | 20 | 35575683 | |
| Pubmed | PUS3 CCT7 APOB HUWE1 RUFY1 DNAH7 BLM SEC24D SLFN13 MGA CLEC16A SDK1 ARHGAP21 CDON | 3.10e-05 | 777 | 170 | 14 | 35844135 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | HSP90B1 CHERP CCT7 HUWE1 INTS8 BLM PARP4 CSTF3 MACF1 TLN2 ATM LAS1L | 3.21e-05 | 582 | 170 | 12 | 20467437 |
| Pubmed | ASXL1 SPEG PHF3 PCDH19 MACF1 KATNIP CLEC16A ARHGAP21 VPS13B AGTPBP1 | 3.48e-05 | 407 | 170 | 10 | 12693553 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 3.65e-05 | 497 | 170 | 11 | 36774506 | |
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | HSP90B1 GBF1 HEATR4 SRRM4 INSRR APOB DNAH7 BPTF CSTF3 AGTPBP1 | 4.53e-05 | 420 | 170 | 10 | 28065597 |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 6.67e-05 | 440 | 170 | 10 | 34244565 | |
| Pubmed | 7.10e-05 | 3 | 170 | 2 | 1971301 | ||
| Pubmed | Factor XI activation in a revised model of blood coagulation. | 7.10e-05 | 3 | 170 | 2 | 1652157 | |
| Pubmed | 7.10e-05 | 3 | 170 | 2 | 23836881 | ||
| Pubmed | USP37 regulates DNA damage response through stabilizing and deubiquitinating BLM. | 7.10e-05 | 3 | 170 | 2 | 34606619 | |
| Pubmed | Expression of mucin 3 and mucin 5AC in arthritic synovial tissue. | 7.10e-05 | 3 | 170 | 2 | 18163520 | |
| Pubmed | 7.10e-05 | 3 | 170 | 2 | 17958740 | ||
| Pubmed | 7.10e-05 | 3 | 170 | 2 | 38875319 | ||
| Pubmed | 7.10e-05 | 3 | 170 | 2 | 21147755 | ||
| Pubmed | GBF1 and Arf1 interact with Miro and regulate mitochondrial positioning within cells. | 7.10e-05 | 3 | 170 | 2 | 30459446 | |
| Pubmed | 7.10e-05 | 3 | 170 | 2 | 25771912 | ||
| Pubmed | The risk for developing cancer in Israeli ATM, BLM, and FANCC heterozygous mutation carriers. | 7.10e-05 | 3 | 170 | 2 | 26778106 | |
| Pubmed | LINE1 contributes to autoimmunity through both RIG-I- and MDA5-mediated RNA sensing pathways. | 7.10e-05 | 3 | 170 | 2 | 29525183 | |
| Pubmed | 7.10e-05 | 3 | 170 | 2 | 20352152 | ||
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 7.80e-05 | 208 | 170 | 7 | 33230847 | |
| Pubmed | KCTD12 DRG2 CENPE UBR4 HUWE1 PEX5L NFATC3 PRKAR1A MACF1 TLN2 SSH2 MGA TNR ARHGAP21 WNK3 | 8.35e-05 | 963 | 170 | 15 | 28671696 | |
| Pubmed | 8.48e-05 | 453 | 170 | 10 | 29656893 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | KCTD12 KNTC1 HSP90B1 GBF1 DRG2 USP11 MAEA UBR4 CCT7 HUWE1 RUFY1 DFFA SEC24D MYG1 PAPOLA ASS1 PRKAR1A MACF1 ATIC | 9.86e-05 | 1455 | 170 | 19 | 22863883 |
| Pubmed | Werner helicase-interacting protein 1 binds polyubiquitin via its zinc finger domain. | 1.06e-04 | 50 | 170 | 4 | 17550899 | |
| Pubmed | 1.06e-04 | 50 | 170 | 4 | 23703321 | ||
| Pubmed | 1.11e-04 | 153 | 170 | 6 | 10718198 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | UBR1 GBF1 HUWE1 MORC2 BLM BPTF S100A11 SETD2 PAPOLA PHF3 TLN2 ATM AGTPBP1 | 1.21e-04 | 774 | 170 | 13 | 15302935 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | UBR1 HSP90B1 MYO9B USP11 DDX52 UBR4 CCT7 RHOT2 HUWE1 ARMCX1 POLR3A BLM TGM3 ASS1 MACF1 ATIC LAS1L MGA | 1.21e-04 | 1353 | 170 | 18 | 29467282 |
| Pubmed | 1.27e-04 | 225 | 170 | 7 | 25277244 | ||
| Pubmed | 1.27e-04 | 225 | 170 | 7 | 12168954 | ||
| Pubmed | 1.42e-04 | 4 | 170 | 2 | 15827139 | ||
| Pubmed | A family of mammalian E3 ubiquitin ligases that contain the UBR box motif and recognize N-degrons. | 1.42e-04 | 4 | 170 | 2 | 16055722 | |
| Pubmed | 1.42e-04 | 4 | 170 | 2 | 26711340 | ||
| Pubmed | 1.42e-04 | 4 | 170 | 2 | 15863839 | ||
| Pubmed | TRIM26 promotes non-small cell lung cancer survival by inducing PBX1 degradation. | 1.42e-04 | 4 | 170 | 2 | 37324936 | |
| Pubmed | 1.42e-04 | 4 | 170 | 2 | 17634426 | ||
| Pubmed | 1.42e-04 | 4 | 170 | 2 | 25135477 | ||
| Pubmed | 1.42e-04 | 4 | 170 | 2 | 15574327 | ||
| Pubmed | 1.42e-04 | 4 | 170 | 2 | 15539948 | ||
| Pubmed | Nox4 and Duox1/2 Mediate Redox Activation of Mesenchymal Cell Migration by PDGF. | 1.42e-04 | 4 | 170 | 2 | 27110716 | |
| Pubmed | The substrate recognition domains of the N-end rule pathway. | 1.42e-04 | 4 | 170 | 2 | 19008229 | |
| Pubmed | Artemis links ATM to G2/M checkpoint recovery via regulation of Cdk1-cyclin B. | 1.42e-04 | 4 | 170 | 2 | 17242184 | |
| Pubmed | 1.42e-04 | 4 | 170 | 2 | 32830538 | ||
| Pubmed | The E3 ubiquitin ligase Mule acts through the ATM-p53 axis to maintain B lymphocyte homeostasis. | 1.42e-04 | 4 | 170 | 2 | 22213803 | |
| Pubmed | 1.43e-04 | 101 | 170 | 5 | 10997877 | ||
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 1.63e-04 | 313 | 170 | 8 | 38270169 | |
| Pubmed | Association of IFIH1 and other autoimmunity risk alleles with selective IgA deficiency. | 1.65e-04 | 22 | 170 | 3 | 20694011 | |
| Pubmed | UBR4 L1TD1 RHOT2 HUWE1 SEC24D MYG1 PAPOLA PRKAR1A MACF1 MGA SDK1 | 1.69e-04 | 591 | 170 | 11 | 15231748 | |
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | 1.74e-04 | 495 | 170 | 10 | 27705803 | |
| Pubmed | MAEA MRPS35 APOB HUWE1 DNAH1 SETD2 PRKAR1A MACF1 EXOSC7 AGTPBP1 | 1.77e-04 | 496 | 170 | 10 | 31343991 | |
| Pubmed | 2.03e-04 | 59 | 170 | 4 | 20855565 | ||
| Pubmed | 2.35e-04 | 5 | 170 | 2 | 19286843 | ||
| Pubmed | 2.35e-04 | 5 | 170 | 2 | 18355440 | ||
| Pubmed | 2.35e-04 | 5 | 170 | 2 | 39056782 | ||
| Pubmed | Identification of disulfide-linked apolipoprotein species in human lipoproteins. | 2.35e-04 | 5 | 170 | 2 | 8245722 | |
| Pubmed | 2.35e-04 | 5 | 170 | 2 | 24089532 | ||
| Pubmed | 2.35e-04 | 5 | 170 | 2 | 20589316 | ||
| Pubmed | 2.35e-04 | 5 | 170 | 2 | 29528433 | ||
| Pubmed | 2.35e-04 | 5 | 170 | 2 | 18316419 | ||
| Pubmed | [Assessment of five thrombophilic genetic polymorphisms among couples with habitual abortion]. | 2.35e-04 | 5 | 170 | 2 | 16711541 | |
| Pubmed | DNA double strand break repair enzymes function at multiple steps in retroviral infection. | 2.35e-04 | 5 | 170 | 2 | 20003485 | |
| Pubmed | 2.35e-04 | 5 | 170 | 2 | 10729222 | ||
| Pubmed | 2.44e-04 | 25 | 170 | 3 | 19372376 | ||
| GeneFamily | Fibronectin type III domain containing | 4.92e-05 | 160 | 108 | 7 | 555 | |
| GeneFamily | Ubiquitin protein ligase E3 component n-recognins | 7.28e-04 | 7 | 108 | 2 | 785 | |
| GeneFamily | Schlafen family | 7.28e-04 | 7 | 108 | 2 | 1110 | |
| GeneFamily | Copines | 1.24e-03 | 9 | 108 | 2 | 829 | |
| GeneFamily | Sterile alpha motif domain containing|MBT domain containing | 1.24e-03 | 9 | 108 | 2 | 1263 | |
| GeneFamily | EF-hand domain containing | 2.02e-03 | 219 | 108 | 6 | 863 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 2.81e-03 | 161 | 108 | 5 | 593 | |
| GeneFamily | Tubulin tyrosine ligase family | 3.07e-03 | 14 | 108 | 2 | 779 | |
| GeneFamily | Chaperonins | 3.53e-03 | 15 | 108 | 2 | 587 | |
| GeneFamily | Dyneins, axonemal | 4.53e-03 | 17 | 108 | 2 | 536 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | BDP1 UBR1 CDK17 MYO9B ANKRD10 UBR4 DGKA FBXW2 ICE1 HUWE1 REV3L UBASH3A SFMBT2 BPTF SETD2 PAPOLA NFATC3 PHF3 PRKAR1A MACF1 SLFN11 TRAF3IP3 ATM SSH2 PLEKHO1 VPS13B | 3.24e-06 | 1492 | 168 | 26 | M40023 |
| Coexpression | LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2 | 1.88e-05 | 176 | 168 | 8 | M39223 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 2.21e-05 | 180 | 168 | 8 | M8239 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 5.39e-08 | 192 | 169 | 9 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.03e-07 | 162 | 169 | 8 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.66e-07 | 199 | 169 | 8 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.42e-06 | 178 | 169 | 7 | c87945146b2734141f07b39d268e0d8086ee0364 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.73e-06 | 184 | 169 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.73e-06 | 184 | 169 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.73e-06 | 184 | 169 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.59e-06 | 191 | 169 | 7 | 3c464645d0e7e423f791bd63bf5bcf11f6b590d3 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.59e-06 | 191 | 169 | 7 | 1c1d13144259b998d4a0e85142f7afef2ef1e63f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.19e-06 | 193 | 169 | 7 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.51e-06 | 194 | 169 | 7 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-05 | 145 | 169 | 6 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.26e-05 | 149 | 169 | 6 | 2a7f71da51c85e04de2123164914122480e60d66 | |
| ToppCell | COVID-19-lung-Mesothelial|lung / Disease (COVID-19 only), tissue and cell type | 2.93e-05 | 156 | 169 | 6 | e1f563869b3bf997eaa2e756e31b53db1a478903 | |
| ToppCell | 15-Airway-Mesenchymal-Airway_Smooth_Muscle|Airway / Age, Tissue, Lineage and Cell class | 4.01e-05 | 165 | 169 | 6 | 531804467601e1ee1f771cffa21501f6d464ae10 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 4.15e-05 | 166 | 169 | 6 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic-Regulatory_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.44e-05 | 168 | 169 | 6 | 1df3c8c7a6dceb901805eaba7f86f9943f4f1a9d | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic-regulatory_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.44e-05 | 168 | 169 | 6 | 1586451d437b70b2dffe41d782b694702dcaf50b | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-regulatory_T_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.06e-05 | 172 | 169 | 6 | 425970e9ce8943f7e2ba6ca958e7a3a29baa798c | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-regulatory_T_cell-regulatory_T_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.06e-05 | 172 | 169 | 6 | ca0cc0e92b6cdce5016f18fcb2ec1508cb222502 | |
| ToppCell | TCGA-Liver|World / Sample_Type by Project: Shred V9 | 5.39e-05 | 174 | 169 | 6 | 452932f08cf53e5949672a025d78cecb874aa4b0 | |
| ToppCell | TCGA-Colorectal-Recurrent_Tumor|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 5.57e-05 | 175 | 169 | 6 | 7f74961436f88c0e380819095e6104489914d765 | |
| ToppCell | TCGA-Colorectal-Recurrent_Tumor-Colorectal_Adenocarcinoma|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 5.57e-05 | 175 | 169 | 6 | bee8f31f036dfcf9fc6ed29156554771a9ee3c60 | |
| ToppCell | COVID-19-kidney-PCT-S3-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.75e-05 | 176 | 169 | 6 | b6497324e3e52f514ce556a3fa0c3011c45dcc7b | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.12e-05 | 178 | 169 | 6 | 3b12db04006db6e94fc45649a4b3a63b92f21a61 | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.31e-05 | 179 | 169 | 6 | b44e2d53b82c3c141bfc6539054b19708200a0d9 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.71e-05 | 181 | 169 | 6 | fc51468c74534b60b4e786bd512d0f1c5dc05de7 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.13e-05 | 183 | 169 | 6 | f142b320023eef00b48d4820c46214c9794d37e7 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-5_PVALB_TRIM67|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.35e-05 | 184 | 169 | 6 | 7f6c8912677764d438ab0555faca344d74c2f483 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.80e-05 | 186 | 169 | 6 | 5784d255e9ca449d375d81938d0fbbd8a7eb44f6 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 7.80e-05 | 186 | 169 | 6 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | COVID-19-kidney-Mito-rich_PCT|kidney / Disease (COVID-19 only), tissue and cell type | 8.03e-05 | 187 | 169 | 6 | 738ec2611b4be6a08eedad16b57fba84e1f11fef | |
| ToppCell | COVID-19-kidney-PCT-S2|kidney / Disease (COVID-19 only), tissue and cell type | 8.52e-05 | 189 | 169 | 6 | 0be5c669b6b308bd98ddb70c84877c62a6244bbd | |
| ToppCell | pdx-Tumor_cells-T8|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 8.77e-05 | 190 | 169 | 6 | b05db0de9b6ae01dd30074453f7de44f7397631e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.77e-05 | 190 | 169 | 6 | 305fbef734c350cfbf786ca7ff6e07093aab56ea | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 9.02e-05 | 191 | 169 | 6 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.02e-05 | 191 | 169 | 6 | 1cb02007adb344f17ef73d58890f91298c7cf5a1 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.02e-05 | 191 | 169 | 6 | 9032aa974aa1b7b1095b8d1b58dcb087358a5001 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.02e-05 | 191 | 169 | 6 | 5717809a1476c20f65bce722c5a57cff92ee0d7a | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T8|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 9.29e-05 | 192 | 169 | 6 | e785135262f4c9cc66c403bf362bb34643b212c5 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.55e-05 | 193 | 169 | 6 | 4979862c0c16e6b4baa4c79894f1d237c861f5a5 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.55e-05 | 193 | 169 | 6 | 53bcd50892c379b2a571751f6eb1062436339fe7 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.55e-05 | 193 | 169 | 6 | c4b22b62f3cc7bf0ec0eba76e1504c236290bbc9 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Mesofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.01e-04 | 195 | 169 | 6 | a52685f76eca269a7d2de8dfc317439483e233fa | |
| ToppCell | (1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.01e-04 | 195 | 169 | 6 | d3fa551bc6f5ee5890af1040415e61ecd5d46201 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Mesofibroblastic-Mesothelia|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.01e-04 | 195 | 169 | 6 | 224deeba2f60def6543a55bb4f5ee6c7fdab3f02 | |
| ToppCell | Control-Neu_4|Control / 5 Neutrophil clusters in COVID-19 patients | 1.04e-04 | 196 | 169 | 6 | b8b7b54ca17a08fa775507bb22b1c7248ada8f40 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.16e-04 | 200 | 169 | 6 | 96701a4d57753f5ec0dd5c7550054bbcc946bc5f | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.16e-04 | 200 | 169 | 6 | 9169a9ec8e9ab95d90a64c5a19ac666a5cf82313 | |
| ToppCell | mLN-Macrophage-LYVE1_Macrophage|Macrophage / Region, Cell class and subclass | 1.16e-04 | 200 | 169 | 6 | e3c15e0e1c2602b0cc9ab8cc50c978d265350c94 | |
| ToppCell | LPS_IL1RA-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.16e-04 | 200 | 169 | 6 | 4992dbf0514d674017315dbd20d91dfec0c608e9 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.16e-04 | 200 | 169 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.16e-04 | 200 | 169 | 6 | 107854f4855fc99c9f7e737eb246f0d868e6c5fd | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_only / Treatment groups by lineage, cell group, cell type | 1.16e-04 | 200 | 169 | 6 | 7c62678cf408aaaf98d6df0fb27814d2007c4521 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 7.15e-05 | 49 | 96 | 5 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Drug | 0179445-0000 [211246-22-9]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.03e-06 | 185 | 165 | 10 | 4755_DN | |
| Drug | Helveticoside [630-64-8]; Down 200; 7.4uM; MCF7; HT_HG-U133A | 8.95e-06 | 186 | 165 | 9 | 3851_DN | |
| Drug | Digitoxigenin [143-62-4]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 1.15e-05 | 192 | 165 | 9 | 4801_DN | |
| Drug | Naltrexone hydrochloride dihydrate [16676-29-2]; Down 200; 9.6uM; HL60; HG-U133A | 1.20e-05 | 193 | 165 | 9 | 1363_DN | |
| Disease | X-21319 measurement | 3.03e-05 | 2 | 163 | 2 | EFO_0800807 | |
| Disease | X-11478 measurement | 9.07e-05 | 3 | 163 | 2 | EFO_0021242 | |
| Disease | Uterine leiomyoma, estrogen-receptor positive breast cancer | 1.27e-04 | 18 | 163 | 3 | EFO_1000649, HP_0000131 | |
| Disease | endoplasmin measurement | 1.81e-04 | 4 | 163 | 2 | EFO_0801570 | |
| Disease | total blood protein measurement | TTC41P ANKRD55 DNAH1 FRK SETD2 NFATC3 RCBTB1 PKHD1 MACF1 CLEC16A | 2.10e-04 | 449 | 163 | 10 | EFO_0004536 |
| Disease | 3-hydroxyhexanoate measurement | 3.00e-04 | 5 | 163 | 2 | EFO_0800378 | |
| Disease | indoleacetoylcarnitine measurement | 4.48e-04 | 6 | 163 | 2 | EFO_0800106 | |
| Disease | familial combined hyperlipidemia (is_marker_for) | 4.48e-04 | 6 | 163 | 2 | DOID:13809 (is_marker_for) | |
| Disease | glucose metabolism disease (implicated_via_orthology) | 4.90e-04 | 28 | 163 | 3 | DOID:4194 (implicated_via_orthology) | |
| Disease | sugar consumption measurement | 5.53e-04 | 120 | 163 | 5 | EFO_0010158 | |
| Disease | Ovarian Mucinous Adenocarcinoma | 6.64e-04 | 31 | 163 | 3 | C1335167 | |
| Disease | Familial hypercholesterolemia | 8.31e-04 | 8 | 163 | 2 | cv:C0020445 | |
| Disease | common bile duct neoplasm (is_marker_for) | 8.31e-04 | 8 | 163 | 2 | DOID:4608 (is_marker_for) | |
| Disease | Intellectual Disability | 8.91e-04 | 447 | 163 | 9 | C3714756 | |
| Disease | celiac disease (is_implicated_in) | 1.33e-03 | 10 | 163 | 2 | DOID:10608 (is_implicated_in) | |
| Disease | polybrominated biphenyl measurement, gestational serum measurement, fetal genotype effect measurement, polybrominated diphenyl ether measurement | 1.61e-03 | 11 | 163 | 2 | EFO_0007959, EFO_0007961, EFO_0007962, EFO_0007964 | |
| Disease | phospholipids:total lipids ratio | 1.69e-03 | 227 | 163 | 6 | EFO_0020946 | |
| Disease | response to angiotensin-converting enzyme inhibitor, Cough | 2.11e-03 | 46 | 163 | 3 | EFO_0005325, HP_0012735 | |
| Disease | Hyperlipoproteinemia Type IIb | 2.27e-03 | 13 | 163 | 2 | C1704417 | |
| Disease | Adenoid Cystic Carcinoma | 2.33e-03 | 100 | 163 | 4 | C0010606 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 2.38e-03 | 243 | 163 | 6 | EFO_0004612, EFO_0020944 | |
| Disease | apolipoprotein A 1 measurement | CMTR1 ANKRD10 APOB DUS2 FRK NFATC3 BANP PTCD2 ABCB11 MACF1 MGA PLEKHO1 | 2.74e-03 | 848 | 163 | 12 | EFO_0004614 |
| Disease | free cholesterol to total lipids in small HDL percentage | 2.84e-03 | 51 | 163 | 3 | EFO_0022285 | |
| Disease | thrombosis (is_implicated_in) | 3.04e-03 | 15 | 163 | 2 | DOID:0060903 (is_implicated_in) | |
| Disease | bilirubin measurement | 3.29e-03 | 442 | 163 | 8 | EFO_0004570 | |
| Disease | Hyperlipoproteinemia Type IIa | 3.46e-03 | 16 | 163 | 2 | C0745103 | |
| Disease | non-alcoholic fatty liver disease | 3.48e-03 | 182 | 163 | 5 | EFO_0003095 | |
| Disease | leukemia | 3.52e-03 | 55 | 163 | 3 | C0023418 | |
| Disease | spinal stenosis | 3.91e-03 | 17 | 163 | 2 | EFO_0007490 | |
| Disease | alkaline phosphatase measurement | ELP5 ATP13A1 C8orf74 APOB CFHR4 DUS2 FRK NFATC3 PTCD2 PRKAR1A ABCB11 MACF1 ARHGAP21 | 4.29e-03 | 1015 | 163 | 13 | EFO_0004533 |
| Disease | glucose homeostasis measurement, acute insulin response measurement | 4.38e-03 | 18 | 163 | 2 | EFO_0006831, EFO_0006896 | |
| Disease | Hypercholesterolemia, Familial | 4.38e-03 | 18 | 163 | 2 | C0020445 | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 4.44e-03 | 276 | 163 | 6 | EFO_0004612, EFO_0020943 | |
| Disease | Cleft palate, cleft lip | 4.67e-03 | 279 | 163 | 6 | EFO_0003959, HP_0000175 | |
| Disease | Hereditary Non-Polyposis Colon Cancer Type 2 | 4.88e-03 | 19 | 163 | 2 | C1333991 | |
| Disease | Colorectal cancer, hereditary nonpolyposis, type 1 | 4.88e-03 | 19 | 163 | 2 | C2936783 | |
| Disease | free cholesterol in very large HDL measurement | 4.93e-03 | 62 | 163 | 3 | EFO_0022273 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PSIKTICLRLDSIEA | 51 | Q8N9N5 | |
| LERESISTTPKCFLE | 561 | Q9Y2R4 | |
| ESLTVEVLRTKGPCV | 261 | A6H8Y1 | |
| TASLECVKEETPRAA | 231 | Q8N7J2 | |
| LRCSAIPENSVKEVL | 256 | Q8IUX8 | |
| VRRQAKEPCVESLVS | 21 | P02652 | |
| LRETKGCSITEAVTI | 76 | Q6P047 | |
| LCISGTEEPEKTLRA | 326 | Q9NXR5 | |
| SIPRAIVESVESCEI | 271 | Q9H568 | |
| IVESVESCEISLRPL | 276 | Q9H568 | |
| EVDTVASECPSLRIK | 166 | Q08AH3 | |
| ASECPSLRIKLLVSE | 171 | Q08AH3 | |
| VSCPLKADSKAVIRE | 721 | Q9HD20 | |
| IPSCIAIRESAKVVD | 31 | Q9P1U1 | |
| ESLRETVSQKDVCVP | 926 | Q9BXX3 | |
| TSIFETIDRKPIIDC | 391 | O95342 | |
| TACVKLLSQESRTEP | 311 | Q3KP44 | |
| ACDILAIDKSLTPVT | 46 | O00273 | |
| RVLDDVSIRSPETKC | 1291 | Q12830 | |
| CPTSLSVVKDRNLTE | 141 | Q5BKX8 | |
| TSQECLAVRTLDPLV | 301 | Q9UPW5 | |
| VELSINPLASCKTDV | 606 | O75129 | |
| LSTVTLRTACPLVDD | 1181 | O75129 | |
| VSRVCAVRQKIPDSL | 1066 | Q8IXJ9 | |
| TSLARPCIARKQVEI | 91 | P00966 | |
| AEIENCSSRLIVPKA | 216 | Q8NCT1 | |
| ICTQTFDETIRKPIS | 16 | Q5TC82 | |
| TLLSPQEIASIRKAC | 11 | Q8NDN9 | |
| CLELVTEFSPKLRQV | 596 | Q75QN2 | |
| VTICSPKVNSVIREA | 1041 | Q8TAB3 | |
| ISRESCEKSEPLLIT | 811 | Q9Y5G9 | |
| LCKSEPLTTERVRTT | 11 | Q9NPJ1 | |
| SLCSVSIEKALPEDR | 1151 | Q15746 | |
| SLLSIRQDDKVVCPR | 366 | Q7L5Y9 | |
| CDLPKVVSRAENLSV | 141 | Q643R3 | |
| VDLEPVSPRSCLTKV | 761 | Q9HCH0 | |
| VSPRSCLTKVELAKS | 766 | Q9HCH0 | |
| IATELRDAPEKTLAC | 141 | Q9UJA3 | |
| LEPCAVTRSTVKISE | 471 | Q8IWI9 | |
| SVVDPALRPKTCISE | 1596 | O60303 | |
| IVRTRDPEKLASCDI | 76 | Q9HB07 | |
| VSCSSVVLRTLRKPA | 221 | Q99677 | |
| DCLKRVSSEPVLSVQ | 406 | Q17RB8 | |
| TRIIPTDIISDLSEC | 116 | O95786 | |
| PLDSSQKVREALTCE | 791 | Q9NRD8 | |
| EKVTDTISRCLTPDA | 756 | Q6ZWH5 | |
| CLKLPVAQRRTVSIE | 406 | P09131 | |
| SIVDSISSEERKLPC | 221 | P23409 | |
| LCETKSEAIARPVTS | 86 | Q8IYB4 | |
| CKIPNTVEEAVRIIT | 646 | Q12996 | |
| IDCSPALVRVIKTTS | 276 | Q12980 | |
| ATAKVITDPDILKTC | 631 | P23743 | |
| SPRVECVLAELKGVT | 301 | Q9Y4W2 | |
| PKLSEDSVSVLVLRC | 376 | P50748 | |
| VDRKNPSLVCVATIA | 201 | Q8NA19 | |
| VCRDITRLPKTVATT | 1676 | P98088 | |
| APCTAIREVSLLKDL | 231 | Q00537 | |
| SRTTPVDLCLLEESV | 1491 | Q9UKK3 | |
| LKTRIVFSESVLPVC | 156 | A1L453 | |
| LRESSPKKEETVARC | 446 | Q68DK7 | |
| KSSVDLKTLCISPRE | 116 | Q15024 | |
| VAATVRELAPRCVVT | 881 | P52790 | |
| QRSSESELCIETPKL | 3231 | Q7Z6Z7 | |
| IVEESIRTCKPAFLS | 2986 | Q9UPN3 | |
| CRPVNASKDILLRVT | 671 | Q7Z442 | |
| PGDRLTEICTKITDV | 576 | Q9Y2X0 | |
| IAVAEPSTSECLRIE | 881 | Q9Y6X9 | |
| ISLAAPKETDCVLTQ | 26 | P51003 | |
| IEKAVVSQRLTESPC | 631 | P14625 | |
| LPCLSTEADKSTVIE | 16 | P42685 | |
| RPEVITALSKVRAEC | 506 | Q9P2D7 | |
| ETECLRIAKPNVSAS | 71 | Q13315 | |
| RSATRINCKVELEVP | 71 | P04114 | |
| VPSAIVSCLEEVSAL | 2246 | Q9Y2F5 | |
| AAIPIAKRCITAVSL | 486 | Q6TFL4 | |
| VSERLSSAKTDCLPV | 596 | P54132 | |
| SAESTNILKLCPREE | 156 | P51878 | |
| VVEILKPLCRSSQST | 351 | Q96SD1 | |
| ESAVLDSIKAQPCRS | 1941 | Q8IZD9 | |
| RPIILCSKDDTESSK | 616 | O94808 | |
| LQPIIDTCTKDAISA | 161 | Q8IWX8 | |
| NIIDCFVSRPTEKTI | 196 | P57773 | |
| NLVDCFISRPTEKTV | 176 | O95452 | |
| LAVLSRSPVTLECVV | 231 | Q4KMG0 | |
| VPATKIEITVSCRNL | 11 | Q8IYJ1 | |
| CLSRPETTETTEVIK | 2191 | Q8WXX0 | |
| IKAITTCATAALERP | 496 | Q86WZ0 | |
| CVLKDSVTETLPRVN | 76 | P03951 | |
| ATTCKDKTLRIIDPR | 191 | Q6QEF8 | |
| AEACTPREVATKEKI | 21 | A0A1B0GTR0 | |
| TVPCLRTCSKSDVEI | 81 | Q92496 | |
| DLASPVLRSVSICTK | 186 | Q5I0G3 | |
| SVTKRCVPLEECLST | 91 | Q86Y78 | |
| TVEVCPSLDIRSEVA | 26 | P14616 | |
| ALKTVNELASPRECI | 1011 | P14616 | |
| QECLAADKIRTSTPT | 1011 | Q9Y4D2 | |
| ITPDNFELCVKTLRI | 1406 | Q92538 | |
| LKDSIVQLCTARPER | 31 | P10644 | |
| IDVEIARSDCRKPLS | 86 | O60676 | |
| CKRTDPVPVTIALDS | 111 | Q8TE02 | |
| SCEVIKAIADTLSIP | 196 | Q9NX74 | |
| LVETKETCFIREPKT | 126 | Q1W209 | |
| KTLSVSEDRSICLQP | 316 | Q9UKT8 | |
| TTLECIASARPVEDL | 311 | Q7Z5N4 | |
| RAKVLCLSPESSAEA | 511 | Q68D06 | |
| VTRRCTVVSVPDSLL | 46 | Q96CX2 | |
| KPLETRLISETTSVC | 231 | Q06136 | |
| RLISETTSVCKPEQV | 236 | Q06136 | |
| KTRIICTITPVSFDE | 301 | Q02224 | |
| PVTLVSRQCTEDIKL | 401 | Q6NT55 | |
| TTLSEPRQAEIRKEC | 521 | Q8N1G2 | |
| PATKVEITVSCRNLL | 21 | Q9HCH3 | |
| PESFKICTTLREEAL | 216 | Q8WV60 | |
| VTPTLRVEDCSIALL | 1196 | P28827 | |
| SKTELTPEAICRRAA | 1056 | Q9H195 | |
| IIDNSLSLKTPSECV | 256 | E9PJI5 | |
| IIDNSLSLKTPSECV | 256 | P0DM63 | |
| IKCITEGLADPEVRT | 726 | Q9Y2M0 | |
| TTDVLTIKTDRCPLR | 201 | P82673 | |
| VTTAVPKSERLSCLL | 126 | Q96GJ1 | |
| TPTKRVCVDTEIKSI | 466 | Q9BZE2 | |
| LAPQALEDVKTVVCR | 221 | Q8IXI1 | |
| ATLTLQSECPETKRK | 121 | Q14872 | |
| EKLCPEASDIATSVR | 181 | Q96T51 | |
| PLCDVSASEVSKAII | 176 | Q9NXP7 | |
| ITPTQVEKFLETCRD | 1006 | O14802 | |
| RAKVLCLSPESSAEA | 511 | Q7Z7L1 | |
| CLIVSVDETIKNPRS | 511 | Q99832 | |
| CSDSARILVEVPTKI | 136 | A0A087WV53 | |
| LPVVTCRTRSVLSEA | 86 | P08F94 | |
| SPTETERCIESLIAV | 6 | P31949 | |
| VDRLARKPNSVVISC | 256 | P55039 | |
| ITARKSSVLVCLVET | 161 | Q9BQ13 | |
| LTPTEKGRCASLEEI | 261 | Q53GL0 | |
| VKDTILCPTIAESRR | 181 | Q6UXX9 | |
| KNCVLLSRPEISTDE | 851 | O94855 | |
| RITAVCKVPDESEVV | 571 | Q08188 | |
| EVDTVASECPSLRIK | 166 | Q68CK6 | |
| ASECPSLRIKLLVSE | 171 | Q68CK6 | |
| TRELVSCKVPSELIS | 361 | Q9P291 | |
| SIRCFIKPTETLERS | 361 | Q2KHT3 | |
| ISCITKFDSKRSPEV | 106 | Q8NAA6 | |
| VSIKQERCDPESVIS | 201 | P24278 | |
| LTVESSEKESCRTPK | 111 | Q8N0U2 | |
| VTVLKEPLSCARRIS | 96 | Q9Y228 | |
| RSIEEAVPAVCKTRT | 86 | P04085 | |
| ETVRRDSCPAVSKIL | 2856 | O60673 | |
| KKSLRSEPSVIIVSC | 2621 | Q15772 | |
| SCRLSVVEVAPSKVT | 686 | Q76I76 | |
| RVLSETLKSFCLEPE | 1436 | A6NE52 | |
| LECAEVKKSSLVPST | 366 | A7MD48 | |
| TLSLRLECSSAIIKP | 31 | Q96PS6 | |
| VTDVVRFIKLTDCAP | 826 | Q5VUG0 | |
| IKPSECQLEVTTERV | 26 | Q92752 | |
| RGPSVTEKEVLTCIL | 1086 | Q8IWV7 | |
| SLCARPDVRTVELIS | 481 | Q6P2S7 | |
| CVETDIPLKTRKTSE | 331 | Q12968 | |
| TKEICVVRFTPVTEE | 1266 | Q92576 | |
| SALLACVREVKVAPS | 226 | Q9H1K6 | |
| CVREVKVAPSELARS | 231 | Q9H1K6 | |
| DRVQDKTCPVIISST | 651 | Q8IYQ7 | |
| PALTLDCSTDVLVKR | 391 | Q9BWV7 | |
| SERTCTLAIIKPDAV | 156 | Q86XW9 | |
| LSDVCDVPTAKIISR | 321 | P31939 | |
| SKTVVKEPVDTRVSC | 771 | Q9BYW2 | |
| CSKDILNPKDVITTR | 141 | O95789 | |
| DCAVPISTSLIKQIA | 2906 | Q7Z7G8 | |
| DSKTVGELLVTICSR | 106 | Q9Y4G6 | |
| VERPVCKDSTRIRIT | 531 | P00734 | |
| VEISKGETSRECVPI | 216 | Q5W5X9 | |
| CTIVEALATIPSRKQ | 4146 | Q5T4S7 | |
| VCNESVRTVIVPSEK | 266 | Q5T5U3 | |
| IRNCLLSVEPAISTK | 291 | Q8NG68 | |
| DTASVDLCIKPKTIR | 96 | Q9NVH6 | |
| KAPVRLQECIELFTT | 776 | P51784 | |
| SPALRCVQTAKLILE | 481 | P57075 | |
| KRDLNVITSVPSELC | 1201 | Q9BYP7 | |
| CQELAVVPDSRSVKV | 71 | A6NN73 | |
| SSLEIVSACRVPSKI | 736 | Q5T7N2 | |
| VSACRVPSKIDEKRL | 741 | Q5T7N2 | |
| CVDSLTSDKASVPIV | 1701 | Q13459 |